EPISODE · Jun 10, 2025 · 25 MIN
New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship
from Keeping Current CME
Which patients with IDH-mutant glioma should receive an isocitrate dehydrogenase (IDH) inhibitor? A top neurosurgeon weighs in. Credit available for this activity expires: 6/9/2026 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002598?ecd=bdc_podcast_libsyn_mscpedu
Embed this episode
NOW PLAYING
New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship
0:00
25:32
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Keeping Current CME?
This episode is 25 minutes long.
When was this Keeping Current CME episode published?
This episode was published on June 10, 2025.
Can I download this Keeping Current CME episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!